ir.tranzyme.com ir.tranzyme.com

ir.tranzyme.com

Investor Relations | Ocera Therapeutics, Inc.

Ocera is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Oceras lead program, OCR-002, is an ammonia scavenger designed to treat hyperammonemia (elevated ammonia in the blood) and associated hepatic encephalopathy, a complication of patients with liver cirrhosis. View all ». Aug 3, 2015. Ocera Therapeutics Reports Second Quarter 2015 Financial Results.

http://ir.tranzyme.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.TRANZYME.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 15 reviews
5 star
8
4 star
5
3 star
1
2 star
0
1 star
1

Hey there! Start your review of ir.tranzyme.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

FAVICON PREVIEW

  • ir.tranzyme.com

    16x16

CONTACTS AT IR.TRANZYME.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Relations | Ocera Therapeutics, Inc. | ir.tranzyme.com Reviews
<META>
DESCRIPTION
Ocera is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Oceras lead program, OCR-002, is an ammonia scavenger designed to treat hyperammonemia (elevated ammonia in the blood) and associated hepatic encephalopathy, a complication of patients with liver cirrhosis. View all ». Aug 3, 2015. Ocera Therapeutics Reports Second Quarter 2015 Financial Results.
<META>
KEYWORDS
1 ocera
2 careers
3 about us
4 management team
5 board of directors
6 partnering
7 news
8 investors
9 investor relations
10 recent releases
CONTENT
Page content here
KEYWORDS ON
PAGE
ocera,careers,about us,management team,board of directors,partnering,news,investors,investor relations,recent releases,events and presentations,investor relations home,corporate governance,management,committee composition,financial information,sec filings
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Relations | Ocera Therapeutics, Inc. | ir.tranzyme.com Reviews

https://ir.tranzyme.com

Ocera is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Oceras lead program, OCR-002, is an ammonia scavenger designed to treat hyperammonemia (elevated ammonia in the blood) and associated hepatic encephalopathy, a complication of patients with liver cirrhosis. View all ». Aug 3, 2015. Ocera Therapeutics Reports Second Quarter 2015 Financial Results.

INTERNAL PAGES

ir.tranzyme.com ir.tranzyme.com
1

2015 BIO Investor Forum | Ocera

http://ir.tranzyme.com/eventdetail.cfm?EventID=163768

Day High: 2.36. Day Low: 2.28. Aug 26, 2016. Delayed 20 min., by eSignal. 2015 BIO Investor Forum. Oct 21, 2015. Location: Parc 55 San Francisco, San Francisco, CA.

2

Ocera Therapeutics Secures $20 Million Debt Facility from Oxford Finance and Silicon Valley Bank (NASDAQ:OCRX)

http://ir.tranzyme.com/releasedetail.cfm?ReleaseID=924947

Jul 30, 2015. File is in Briefcase. Ocera Therapeutics Secures $20 Million Debt Facility from Oxford Finance and Silicon Valley Bank. PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., July 30, 2015 (GLOBE NEWSWIRE) - Ocera Therapeutics, Inc. (NASDAQ: OCRX. We are very pleased to continue to work with the Ocera team and believe in their approach of tackling some of the greatest unmet needs in liver disease, said Jennifer Friel Goldstein, Managing Director at Silicon Valley Bank. OCR-002 has continue...

3

Presentations & Events | Ocera

http://ir.tranzyme.com/events.cfm

Day High: 2.36. Day Low: 2.28. Aug 26, 2016. Delayed 20 min., by eSignal. Investor Presentation - August 2016. File is in Briefcase. Sep 27, 2016. Ladenburg Thalmann 2nd Annual Healthcare Conference. Ladenburg Thalmann 2nd Annual Healthcare Conference. Please sign up for Email alerts. Jun 22, 2016. JMP Securities 2016 Life Sciences Conference. Jun 10, 2016. Jefferies 2016 Healthcare Conference. Location: Grand Hyatt, New York, NY. Jun 8, 2016. 2016 BIO International Convention. Apr 15, 2016. Apr 13, 2016.

4

Stock Information | Ocera

http://ir.tranzyme.com/stockquote.cfm

002 ( 0.873%). 3:59 PM ET on Aug 26, 2016. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and Ocera Therapeutics, Inc. does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. Sign up for email alerts.

5

Rodman & Renshaw 17th Annual Global Investment Conference | Ocera

http://ir.tranzyme.com/eventdetail.cfm?EventID=163767

Day High: 2.36. Day Low: 2.28. Aug 26, 2016. Delayed 20 min., by eSignal. Rodman and Renshaw 17th Annual Global Investment Conference. Sep 10, 2015. Location: St. Regis Hotel, Louis XVI B (2nd floor), New York, NY.

UPGRADE TO PREMIUM TO VIEW 9 MORE

TOTAL PAGES IN THIS WEBSITE

14

SOCIAL ENGAGEMENT



OTHER SITES

ir.traconpharma.com ir.traconpharma.com

TRACON Pharmaceuticals - Investors - Investors

Annual Reports and Proxies. Targeted Therapeutics for Cancer and Ophthalmology. 160;  0.08. Data as of 08/17/15 4:00 pm ET. Minimum 20 minute delay. August 5, 2015. TRACON Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update. July 29, 2015. TRACON to Report Second Quarter 2015 Company Highlights and Financial Results on August 5, 2015. July 1, 2015. There are currently no events scheduled. Data Provided by Thomson Reuters. Minimum 20 minutes delayed.

ir.tractorsupply.com ir.tractorsupply.com

Corporate Profile

Click Here to Sign Up for Email Alerts. News and Market Information. News and Market Information. July, 2015, 5:00 PM ET. Second Quarter 2015 Earnings Webcast. William Blair and Co. 35th Annual Growth Stock Conference Presentation. Tractor Supply Company to Be Title Sponsor of New Multi-Purpose Equestrian Facility at Franklins Park at Harlinsdale Farm. Tractor Supply Company Teams With IBM for Redesigned Website, Cloud Transformation. Tractor Supply Company Declares Quarterly Dividend. THE SITE AND THE C...

ir.tradeford.com ir.tradeford.com

Iran B2B Marketplace - Products from Iranian Suppliers & Manufacturers

Welcome to TradeFord.com, Join Free. Find Iranian Suppliers, Iranian Manufacturers and Companies. Offering quality Made in Iran Products! Create FREE Company Website. Don't know your target market? Wanted to market your products globally? Join TradeFord.com to list your products online for Free and reach thousands of global buyers and importers. Take 1 Minute to Post Your Products Now! Take 1 Minute to Start Global Trade Now! Take 1 Minute to Post Your Buying Need! Ferdows Textile Co. (Seller). Has faced...

ir.transatlanticpetroleum.com ir.transatlanticpetroleum.com

Investor Relations | TransAtlantic Petroleum

Skip to main navigation. TransAtlantic Petroleum is an international energy producer engaged in the acquisition, exploration, development and production of oil and natural gas. Our objective is to acquire assets with known production potential in countries that have favorable fiscal terms and prices. We utilize North American technology to enhance and commercialize production. We currently hold interests in Turkey and Bulgaria. Mar 28, 2018. Mar 21, 2018. Mar 30, 2018 1:29 AM EDT.

ir.transenterix.com ir.transenterix.com

Investors Overview - TransEnterix, Inc.

Corporate News & Events. Events & Presentations. Aug 17, 2015. TransEnterix, Inc. Amends Existing Loan Agreement with Oxford Finance and Silicon Valley Bank. Increases available net borrowing capacity to $30 million RESEARCH TRIANGLE PARK, N.C.- (BUSINESS WIRE)- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today annou. Aug 6, 2015. View all press releases. Aug 6, 2015 at 4:30 PM ET.

ir.tranzyme.com ir.tranzyme.com

Investor Relations | Ocera Therapeutics, Inc.

Ocera is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Oceras lead program, OCR-002, is an ammonia scavenger designed to treat hyperammonemia (elevated ammonia in the blood) and associated hepatic encephalopathy, a complication of patients with liver cirrhosis. View all ». Aug 3, 2015. Ocera Therapeutics Reports Second Quarter 2015 Financial Results.

ir.travel.pl ir.travel.pl

IR.TRAVEL.PL - w drodze, fotograficzne wspomnienia autora

To tu, to tam coś się zobaczyło. I chciałbym to na zdjeciach Wam pokazać .

ir.travelport.com ir.travelport.com

Travelport: leading travel commerce platform | Investor center overview

Travelport Merchandising Platform for Airlines. Travelport Rooms and More for Agencies. Vice President, Investor Relations. 44 (0)1753 288 857. Manager, Investor Relations. 44 (0)1753 288 634. News alerts by email. We are a leading travel commerce platform providing distribution, technology, payment and other solutions for the $8 trillion global travel and tourism industry. With approximately 3,400 full-time employees and 2014 net revenue of $2.1 billion, our primarily transaction-based pricing model...

ir.travelzoo.com ir.travelzoo.com

Investor Relations - Travelzoo

See this week’s Top 20. What type of deals? Annual Reports and Proxies. Directors and Executive Officers. Business Conduct and Ethics. Annual Reports and Proxies. Directors and Executive Officers. Business Conduct and Ethics. 013 ( 1.75%). 3:48 PM ET on Mar 29, 2018. Delayed at least 20 minutes. Mar 19, 2018. Travelzoo Survey: 2018 to See Africa Boom among Avid Chinese Travelers. Mar 16, 2018. Travelzoo to Broadcast St. Patrick's Day Parade from Ireland on Facebook Live. Mar 7, 2018. Mar 5, 2018. Begin t...

ir.travian.com ir.travian.com

TRAVIAN - the online multiplayer strategy game

The time has come, Travian Kingdoms open Beta international server is now. Open! TRAVIAN - the multiplayer strategy game. TRAVIAN is one of the most popular browser games in the world. As a player in TRAVIAN, you will build your own empire, recruit a mighty army, and fight with your allies for game world hegemony. Register here for free! International open beta server. Play TRAVIAN: Legends now. Register on the latest. Game world and enjoy. Being one of the. Become part of our community now! 2004 - 2015 ...

ir.tredegar.com ir.tredegar.com

Investor Relations Home » Tredegar

A GLOBAL MANUFACTURER OF PLASTIC FILMS AND ALUMINUM EXTRUSIONS. Tredegar (NYSE:TG) has a long history of generating solid financial. Returns and a reputation for consistently delivering on its. Click Here for Investor Presentations. 160;- 0.56. 08/07/15 4:00 pm ET. Minimum 20 minute delay. Tredegar Board Declares Dividend. Tredegar Reports Second-Quarter 2015 Results. Tredegar Announces Schedule for Second-Quarter Earnings. Tredegar Downsizing Film Products Facility in Lake Zurich, IL. Canton, MA 02021.